Scotia Capital Inc. Abbott Laboratories Transaction History

Scotia Capital Inc.

$17 Billion
Q2 2024

A detailed history of Scotia Capital Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Scotia Capital Inc. holds 92,847 shares of ABT stock, worth $10.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

92,847

Previous 93,823 1.04%

Holding current value

$10.6 Million

Previous $10.7 Million 9.53%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $98,312 - $109,741	-976 Reduced 1.04%	92,847 $9.65 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $613,750 - $677,859	-5,604 Reduced 5.64%	93,823 $10.7 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $360,760 - $441,600	-4,000 Reduced 3.87%	99,427 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $2.06 Million - $2.47 Million	-21,560 Reduced 17.25%	103,427 $10 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $524,862 - $584,806	-5,208 Reduced 4.0%	124,987 $13.6 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $144,805 - $170,444	1,495 Added 1.16%	130,195 $13.2 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $1.23 Million - $1.45 Million	-12,975 Reduced 9.16%	128,700 $14.1 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $2.88 Million - $3.33 Million	-29,735 Reduced 17.35%	141,675 $13.7 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $1.92 Million - $2.32 Million	-18,772 Reduced 9.87%	171,410 $18.6 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $1.02 Million - $1.24 Million	8,926 Added 4.92%	190,182 $22.5 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $3.29 Million - $4.03 Million	-28,482 Reduced 13.58%	181,256 $25.5 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $602,782 - $666,853	-5,167 Reduced 2.4%	209,738 $24.8 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $2.41 Million - $2.84 Million	22,776 Added 11.85%	214,905 $24.9 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $864,080 - $1.02 Million	7,939 Added 4.31%	192,129 $23 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.12 Million - $1.22 Million	10,681 Added 6.16%	184,190 $20.2 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $15.9 Million - $19.3 Million	173,509 New	173,509 $18.9 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $10.8 Million - $13.9 Million	-141,545 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $2.44 Million - $3.57 Million	-38,881 Reduced 21.55%	141,545 $11.2 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $3.04 Million - $3.38 Million	-38,682 Reduced 17.65%	180,426 $15.7 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $883,380 - $957,859	10,794 Added 5.18%	219,108 $18.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $2.64 Million - $3.08 Million	36,180 Added 21.02%	208,314 $17.5 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $6.47 Million - $7.82 Million	-97,672 Reduced 36.2%	172,134 $13.8 Million
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $1.8 Million - $2.03 Million	27,397 Added 11.3%	269,806 $19.5 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $5.86 Million - $7.08 Million	-96,447 Reduced 28.46%	242,409 $17.8 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $48,531 - $53,564	843 Added 0.25%	338,856 $20.2 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $2.94 Million - $3.33 Million	52,312 Added 18.31%	338,013 $20.3 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $1.33 Million - $1.42 Million	24,774 Added 9.49%	285,701 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $147,159 - $164,245	3,062 Added 1.19%	260,927 $13.9 Million
Q2 2017 Aug 15, 2017	BUY	N/A	257,865	257,865 $12.5 Million

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Abbott Laboratories Transaction History